Researcher
Peter Sinnaeve
- Disciplines:Cardiac and vascular medicine
Affiliations
- Cardiology (Division)
Member
From27 Sep 2004 → Today
Projects
1 - 7 of 7
- Patient preferences in cardiology: methodological aspects and integration decision-makingFrom6 Sep 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- The impact of hospital context on quality improvement for STEMI patientsFrom1 May 2014 → 22 Jan 2018Funding: Own budget, for example: patrimony, inscription fees, gifts
- Regulation of the transcriptome by circulating microRNAs in patients with acute coronary syndromes.From1 Sep 2013 → 29 May 2019Funding: FWO fellowships
- The role of microRNAs in the regulation of inflammation and oxidative stress in monocytes during obesity and associated metabolic disorders.From1 Oct 2012 → 30 Sep 2015Funding: FWO fellowships
- Cellular Interactions and Heterogeneity in Ischemic Cardiovascular DiseaseFrom1 Nov 2010 → 31 Oct 2018Funding: BOF - Concerted Research Project from 1994
- Light-based imaging of the coronary arteries: identification of vulnerable plaque and assessment of vessel wall healing.From1 Jan 2009 → 31 Dec 2013Funding: FWO research project
- Vascular biology.From1 Jan 2009 → 31 Dec 2015Funding: FWO scientific research network
Publications
1 - 10 of 215
- Consensus validation of a screening tool for cardiovascular pharmacotherapy in geriatric patients: the RASP_CARDIO list (Rationalization of Home Medication by an Adjusted STOPP list in Older Patients)(2022)
Authors: Laura Hellemans, Jos Tournoy, Peter Verhamme, Peter Sinnaeve, Rik Willems, Christophe Vandenbriele, Lucas Van Aelst, Thomas Vanassche, Lorenz Van der Linden
Pages: 1467 - 1476 - The Effect of Coronary Lesion Complexity and Preprocedural Revascularization on 5-Year Outcomes After TAVR(2022)
Authors: Lennert Minten, Johannes Bennett, Tom Adriaenssens, Walter Desmet, Peter Sinnaeve, Peter Verbrugghe, Steven Jacobs, Christophe Dubois
Pages: 1611 - 1620 - Selatogrel and Other P2Y(12) Inhibitors' Putative Off-Target Effects(2022)
Authors: Peter Sinnaeve
Pages: 153 - 154 - Adherence to quality indicators for ST-elevation myocardial infarction and its relation to mortality: a hospital network analysis from the Belgian STEMI database(2021)
Authors: Peter Sinnaeve
Pages: 601 - 607 - 2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation(2021)
Authors: Peter Sinnaeve, Thomas Vanassche
Pages: 1612 - 1676 - 2021 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation (vol 23, pg 1612, 2021)(2021)
Authors: Jan Steffel, Ronan Collins, Matthias Antz, Pieter Cornu, Lien Desteghe, Karl Georg Haeusler, Jonas Oldgren, Holger Reinecke, Vanessa Roldan-Schilling, Nigel Rowell, et al.
Pages: 1676 - 1676 - Life-threatening paraneoplastic cardiovascular events in ALK-positive anaplastic large cell lymphoma.(2021)
Authors: Björn Meijers, Ann Mertens, Peter Sinnaeve
Pages: 1 - 3 - Evaluation and management of cancer patients presenting with acute cardiovascular disease: a Consensus Document of the Acute CardioVascular Care (ACVC) association and the ESC council of Cardio-Oncology-Part 1: acute coronary syndromes and acute pericardial diseases(2021)
Authors: Peter Sinnaeve
Pages: 947 - 959 - Clec4e-Receptor Signaling in Myocardial Repair After Ischemia-Reperfusion Injury(2021)
Authors: Denise Veltman, Peter Pokreisz, Piet Claus, Willy Gsell, Uwe Himmelreich, Peter Sinnaeve
Pages: 631 - 646 - Antithrombotic treatment after surgical and transcatheter heart valve repair and replacement(2021)
Authors: Peter Verbrugghe, Marie Lamberigts, Thomas Vanassche, Bart Meyns, Wouter Oosterlinck, Filip Rega, Tom Adriaenssens, Lucas Van Hoof, Christophe Vandenbriele, Peter Sinnaeve, et al.
Patents
1 - 3 of 3